Status:
WITHDRAWN
Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease
Lead Sponsor:
Mayo Clinic
Conditions:
Fibromuscular Dysplasia of Arteries
Segmental Arterial Mediolysis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The researchers are trying to see whether contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography improves arterial wall visualization and identifies...
Detailed Description
Aims, purpose, or objectives: 1. To describe whether contrast-enhanced ultrasonography, strain imaging, and 3-D volume ultrasonography are helpful to characterize affected arteries and improve the im...
Eligibility Criteria
Inclusion
- Diagnosis of fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
- Adult male and non-pregnant female patient 18-100 years of age.
- Patients who are able and willing to sign the informed consent will be enrolled.
Exclusion
- Missing records to determine whether or not they have fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
- Patients who do not accept to participate in research studies.
- Prior contraindication to contrast agent.
- Women who are breastfeeding or pregnant
- Patients less than 18 yo
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03335020
Start Date
April 1 2018
End Date
December 31 2020
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905